FindTrial
Sign In

To study how children immune systems react to serious chest infections

Immunological profile of children with empyema thoracis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/091480
Enrollment
75
Registered
2025-07-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J869- Pyothorax without fistula

Interventions

Intervention1: Nil: Nil

Sponsors

Department of Paediatrics
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children with empyema thoracis confirmed on pleural tap as per British thoracis guidelines

Exclusion criteria

Exclusion criteria: Children who have received intravenous immunoglobulins in last 3 months Children who have received blood products in last 3 months

Design outcomes

Primary

MeasureTime frame
Proportion of children with B cell defectsTimepoint: At baseline—

Secondary

MeasureTime frame
Proportion of children with empyema thoracis with T cell,natural killer cell & leucocyte adhesion deficiency defect Secondary causes of immunodeficiency like malnutrition,human immunodeficiency virus,chronic disorders like chronic liver disease,chronic kidney diseaseTimepoint: At baseline—

Countries

India

Contacts

Public ContactSimran Dhamija

Maulana Azad Medical College

drmonicajuneja@gmail.com9968604311

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026